Le Lézard
Classified in: Health, Science and technology
Subjects: WOM, DEI

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome

TORONTO, April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating, constipation, and diarrhea. Misunderstood and stigmatized, this condition significantly impacts individuals' quality of life. World IBS Day 2024 includes awareness for patients with IBS. World IBS Day is now recognized in 17 countries. Events are listed on the World IBS Day website. Use the hashtag #WorldIBSDay2024 to raise awareness on April 19th.

Myths confuse patients preventing them from taking the first step in seeking treatment. Myth #1: IBS is a rare condition. It affects 10-15% globally and is not a rare condition. While more women are diagnosed with IBS, IBS is diagnosed in both women and men. Myth #2: IBS symptoms are the same in everyone. IBS can have diarrhea, constipation or a mixture of both. Abdominal pain and/or bloating is common in all forms. Myth #3: The right diet will cure IBS. The only diet found helpful for people with IBS is the low FODMAP diet. Is not a permanent diet, rather it helps patients understand which foods might be bothersome. Myth #4: IBS is all in your head. IBS involves the gut-brain axis and symptoms in the gut often overload the brain with signals that they are in distress.

World IBS Day was established by Jeffrey Roberts. Jeffrey has been an IBS sufferer for more than three decades. Jeffrey states that "World IBS Day was created to show patients that they are not alone living with IBS." He adds, "We were very grateful to add Ardelyx, Inc as our Lead Partner for 2024 who is leading our Light Up The Sky for IBS campaign. We are also thankful to include AbbVie and Ironwood as Partners for 2024."

"We're honored to join World IBS Day in their campaign to Light Up the Sky on April 19th, to bring visibility to the IBS community and the significant impact the disease has on patients' quality of life," said Johannah Ruddy, M.Ed, Director, Patient Advocacy of Ardelyx. "At Ardelyx, we're dedicated to advancing innovation and improving patient care for individuals living with IBS."

About Jeffrey Roberts:

Jeffrey Roberts, M.Ed, BSc is an IBS Patient Advocate. He was the creator of the first internet community for IBS sufferers in 1995. He currently runs the IBS Patient Support Group, is the co-founder of Tuesday Night IBS and founded World IBS Day in 2019. He has testified to the US FDA numerous times sharing what it is like to live with IBS.

About Ardelyx, Inc.:

Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor) as well as early-stage pipeline candidates. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada., please visit ardelyx.com.

Media Contact:
Jeffrey Roberts, MSEd, BSc
[email protected] 



These press releases may also interest you

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...

17 mai 2024
The Honourable Seamus O'Regan Jr., Minister of Labour and Seniors, on behalf of the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Tom Osborne, Newfoundland and Labrador's Minister of Health and Community Services will make...

17 mai 2024
MOJO Health is excited to announce the unveiling of its revolutionary Health Care Registry ? a new in-kind tool designed to empower individuals to actively contribute to the well-being of their loved ones facing cancer and other serious diagnoses...

17 mai 2024
On May 17, in a significant collaborative effort, the Associated General Contractors of California (AGC of California) and PCL Construction recently hosted a Mental Health Awareness Stand Down. The event took place at PCL's jobsite within the Los...

17 mai 2024
IntelGenx Technologies Corp. (the "Company" or "IntelGenx") (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announced today that the Québec Superior Court (Commercial...

News published on and distributed by: